Cardio Diagnostics Holdings CDIO Income Statement (2021-2026)

NASDAQ CDIO
$2.22 +0.23 (+11.56%)
As of: Aug 20, 2026 · 3:59 PM EDT
Income Statement Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
950.000.00M0.01M0.01M0.02M0.01M0.01M0.00M940.000.01M0.00M0.00M0.00M0.01M
Operating items
Research & Development (Quarter)
0.02M0.03M0.00M-0.03M0.05M0.03M0.03M0.02M0.01M0.06M0.01M1.09M0.12M0.13M0.19M
Selling, General & Administrative (Quarter)
0.21M0.75M1.13M2.32M1.56M2.51M1.38M1.49M4.12M1.29M1.42M0.04M1.28M1.69M1.71M-0.01M1.46M1.14M
Restructuring Costs (Quarter)
0.06M0.06M
Other Operating Expenses (Quarter)
721.000.02M-0.05M-0.05M0.02M0.09M0.09M0.02M0.04M0.03M0.04M-0.06M-0.01M0.39M0.23M1.47M0.20M0.17M
Operating Expenses (Quarter)
721.000.02M0.23M0.79M1.15M2.38M1.70M2.55M1.45M1.55M4.17M1.29M1.42M1.52M1.63M1.69M1.71M1.47M1.79M1.50M
Operating Income (Quarter)
-721.00-0.15M-0.23M-0.79M-1.15M-2.38M-1.70M-2.55M-1.44M-1.54M-4.16M-1.28M-1.41M-1.52M-1.63M-1.68M-1.71M-1.46M-1.78M-1.50M
EBIT (Quarter)
-721.00-0.15M-0.23M-0.79M-1.15M-2.38M-1.70M-2.55M-1.44M-1.54M-4.16M-1.28M-1.41M-1.52M-1.63M-1.68M-1.71M-1.46M-1.78M-1.50M
Non-operating items
Non Operating Investment Income (Quarter)
484.000.00M0.01M0.37M
Other Non Operating Income (Quarter)
-0.06M-0.11M0.67M-0.36M-0.49M-0.88M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Net income details
EBT (Quarter)
-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M-1.47M-1.79M-1.50M
Profit After Tax (Quarter)
-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M-1.47M-1.79M-1.50M
Income from Continuing Operations (Quarter)
-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M-1.47M-1.79M-1.50M
Consolidated Net Income (Quarter)
-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M-1.47M-1.79M-1.50M
Income towards Parent Company (Quarter)
-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M-1.47M-1.79M-1.50M
Net Income towards Common Stockholders (Quarter)
-721.00-0.14M-0.29M-0.84M-1.15M-2.38M-1.03M-4.02M-1.93M-1.39M-4.16M-1.29M-1.41M-1.52M-1.64M-1.68M-1.71M-1.47M-1.79M-1.50M
Additional items
EPS (Basic) (Quarter)
-3.74-1.34-3.89-5.31-23.11-3.25-11.78-4.87-3.29-5.93-1.71-1.73-1.70-0.97-0.97-0.98-0.84-0.63-0.51
EPS (Diluted) (Quarter)
-3.74-2.06-4.65-5.22-23.11-3.25-11.78-4.87-3.29-5.93-1.71-1.73-1.70-0.97-0.97-0.98-0.84-0.63-0.51
Shares Outstanding (Quarter)
0.04M0.22M0.22M0.22M0.10M0.32M0.34M0.40M0.42M0.70M0.75M0.81M0.90M1.69M1.74M1.76M1.75M2.84M2.96M
Shares Outstanding (Diluted) (Quarter)
0.04M0.14M0.18M0.22M0.10M0.32M0.34M0.40M0.42M0.70M0.75M0.81M0.90M1.69M1.74M1.76M1.75M2.84M2.96M
Shares Outstanding (Entity) (Quarter)
0.05M0.04M0.22M0.22M0.22M0.10M0.32M0.37M0.44M0.42M0.72M0.78M0.81M0.90M1.74M1.74M1.77M1.83M2.96M2.96M
EBITDA (Quarter)
-721.00-0.15M-0.23M-0.79M-1.15M-2.38M-1.70M-2.55M-1.44M-1.54M-4.16M-1.28M-1.41M-1.52M-1.63M-1.68M-1.71M-1.46M-1.78M-1.50M
Interest Expenses (Quarter)
0.34M0.01M5.02M1.05M0.99M-6.62M0.06M0.84M0.77M0.00M0.06M0.58M0.10M0.00M0.07M0.31M